JSPR - Jasper Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

JSPR is currently covered by 6 analysts with an average price target of $26.12. This is a potential upside of $23.72 (988.33%) from yesterday's end of day stock price of $2.4.

Jasper Therapeutics's activity chart (see below) currently has 23 price targets and 48 ratings on display. The stock rating distribution of JSPR is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 1.79% with an average time for these price targets to be met of 56.63 days.

Highest price target for JSPR is $65, Lowest price target is $5, average price target is $24.4.

Most recent stock forecast was given by SILVAN TUERKCAN from JMP on 08-Jul-2025. First documented stock forecast 14-Oct-2021.

Currently out of the existing stock ratings of JSPR, 28 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$12

$9.5 (380.00%)

2 months 15 days ago
(08-Jul-2025)

0/5 (0%)

$8.98 (297.35%)

Buy

$5

$2.5 (100.00%)

2 months 15 days ago
(08-Jul-2025)

0/4 (0%)

$1.98 (65.56%)

Buy

$20

$17.5 (700.00%)

$40

2 months 16 days ago
(07-Jul-2025)

0/9 (0%)

$16.96 (557.89%)

Buy

$20

$17.5 (700.00%)

2 months 16 days ago
(07-Jul-2025)

0/2 (0%)

$16.96 (557.89%)

Buy

$65

$62.5 (2500.00%)

$80

4 months 8 days ago
(15-May-2025)

0/3 (0%)

$60.13 (1234.70%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is JSPR (Jasper Therapeutics) average time for price targets to be met?

On average it took 56.63 days on average for the stock forecasts to be realized with a an average price target met ratio 1.79

Which analyst has the current highest performing score on JSPR (Jasper Therapeutics) with a proven track record?

JUDAH FROMMER

Which analyst has the current lower performing score on JSPR (Jasper Therapeutics) with a proven track record?

JUSTIN ZELIN

Which analyst has the most public recommendations on JSPR (Jasper Therapeutics)?

Judah Frommer works at MORGAN STANLEY and has 7 price targets and 5 ratings on JSPR

Which analyst is the currently most bullish on JSPR (Jasper Therapeutics)?

Michael King with highest potential upside - $66

Which analyst is the currently most reserved on JSPR (Jasper Therapeutics)?

Gregory Renza with lowest potential downside - $2.5

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?